Autophagy in blood cancers: biological role and therapeutic implications
暂无分享,去创建一个
F. Patrone | G. Helgason | F. Montecucco | A. Nencioni | M. Cea | A. Carella | T. Holyoake | Vd Longo
[1] T. Morgan,et al. Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression , 2013, Experimental Gerontology.
[2] D. Colomer,et al. Autophagy controls everolimus (RAD001) activity in mantle cell lymphoma , 2013, Autophagy.
[3] D. White,et al. Clarithromycin enhances dasatinib-induced cell death in chronic myeloid leukemia cells, by inhibition of late stage autophagy , 2013, Leukemia & lymphoma.
[4] R. Stahel,et al. Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin , 2012, BMC Cancer.
[5] G. Bhagat,et al. Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation , 2012, Science.
[6] S. Altiok,et al. Autophagy induced by conventional chemotherapy mediates tumor cell sensitivity to immunotherapy. , 2012, Cancer research.
[7] J. McCubrey,et al. Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia , 2012, Leukemia.
[8] M. Bogyo,et al. Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide. , 2012, Blood.
[9] N. Munshi,et al. Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition. , 2012, Blood.
[10] B. Zhivotovsky,et al. Sorafenib has potent antitumor activity against multiple myeloma in vitro, ex vivo, and in vivo in the 5T33MM mouse model. , 2012, Cancer research.
[11] P. Conti,et al. Fasting Enhances the Response of Glioma to Chemo- and Radiotherapy , 2012, PloS one.
[12] K. Schlie,et al. Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity , 2012, Immunological reviews.
[13] D. Ribatti,et al. Antiangiogenic therapeutic approaches in multiple myeloma. , 2012, Current cancer drug targets.
[14] David B. Allison,et al. Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study , 2012, Nature.
[15] M. Priault,et al. Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence , 2012, Cell Death and Disease.
[16] A. Thorburn,et al. The vitamin E analogue α-TEA stimulates tumor autophagy and enhances antigen cross-presentation. , 2012, Cancer research.
[17] V. Deretic. Autophagy: An Emerging Immunological Paradigm , 2012, The Journal of Immunology.
[18] A. Ballestrero,et al. Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience. , 2012, Seminars in hematology.
[19] S. Grant,et al. Inhibition of Bcl-2 antiapoptotic members by obatoclax potently enhances sorafenib-induced apoptosis in human myeloid leukemia cells through a Bim-dependent process. , 2012, Blood.
[20] J. Tamburini,et al. The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia , 2012, Leukemia.
[21] R. Xiang,et al. Abstract 3535: Lymphoma-associated macrophages benefit for tumor progress via overexpressing legumain to degrade extracellular matrix in diffuse large B-cell lymphoma , 2012 .
[22] D. Sabatini,et al. mTOR Signaling in Growth Control and Disease , 2012, Cell.
[23] Robert Clarke,et al. Guidelines for the use and interpretation of assays for monitoring autophagy , 2012 .
[24] W. Qian,et al. Perifosine induces protective autophagy and upregulation of ATG5 in human chronic myelogenous leukemia cells in vitro , 2012, Acta Pharmacologica Sinica.
[25] Vito Pistoia,et al. Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy , 2012, Science Translational Medicine.
[26] M. Prætorius-Ibba,et al. FTY720-induced blockage of autophagy enhances anticancer efficacy of milatuzumab in mantle cell lymphoma , 2012, Autophagy.
[27] A. Carella,et al. Clarithromycin potentiates tyrosine kinase inhibitor treatment in patients with resistant chronic myeloid leukemia , 2012, Leukemia & lymphoma.
[28] Kai-Chien Yang,et al. Lapatinib Induces Autophagy, Apoptosis and Megakaryocytic Differentiation in Chronic Myelogenous Leukemia K562 Cells , 2011, PloS one.
[29] J. Byrd,et al. FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death. , 2011, Blood.
[30] E. Unanue,et al. Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells , 2011, The Journal of experimental medicine.
[31] M. Eisenstein,et al. The autophagy protein Atg12 associates with antiapoptotic Bcl-2 family members to promote mitochondrial apoptosis. , 2011, Molecular cell.
[32] Jie Sun,et al. Autophagy Inhibition Enhances Daunorubicin-Induced Apoptosis in K562 Cells , 2011, PloS one.
[33] J. Ruan. Antiangiogenic therapies in non-Hodgkin's lymphoma. , 2011, Current cancer drug targets.
[34] W. Fiedler,et al. Clinical experience with antiangiogenic therapy in leukemia. , 2011, Current cancer drug targets.
[35] M. Priault,et al. ATRA-induced upregulation of Beclin 1 prolongs the life span of differentiated acute promyelocytic leukemia cells , 2011, Autophagy.
[36] D. Rubinsztein,et al. Autophagy and Aging , 2011, Cell.
[37] D. Rubinsztein,et al. Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. , 2011, The Journal of clinical investigation.
[38] H. Ke,et al. Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13 , 2011, Cell.
[39] T. Holyoake,et al. Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML. , 2011, Blood.
[40] E. Morselli,et al. p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200 , 2011, Cell cycle.
[41] Andrea Ballabio,et al. TFEB Links Autophagy to Lysosomal Biogenesis , 2011, Science.
[42] H. Nakano,et al. An unexpected role for autophagy in degranulation of mast cells , 2011, Autophagy.
[43] J. McCubrey,et al. Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia , 2011, Leukemia.
[44] Seamus J. Martin,et al. Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. , 2011, Molecular cell.
[45] B. Yan,et al. Discovery of small molecules that target autophagy for cancer treatment. , 2011, Current medicinal chemistry.
[46] E. Soilleux,et al. The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance , 2011, The Journal of experimental medicine.
[47] B. Viollet,et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 , 2011, Nature Cell Biology.
[48] B. Viollet,et al. Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy , 2011, Science.
[49] B. Druker,et al. Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. , 2011, The Journal of clinical investigation.
[50] S. Morrison,et al. FIP200 is required for the cell-autonomous maintenance of fetal hematopoietic stem cells. , 2010, Blood.
[51] D. Sabatini,et al. mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.
[52] O. Ilkayeva,et al. Autophagy is Essential to Suppress Cell Stress and to Allow BCR-Abl-Mediated Leukemogenesis , 2010, Oncogene.
[53] A. Ballestrero,et al. Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. , 2010, Experimental hematology.
[54] G. Kroemer,et al. Autophagy and the integrated stress response. , 2010, Molecular cell.
[55] H. Mitsuya,et al. Clarithromycin attenuates autophagy in myeloma cells. , 2010, International journal of oncology.
[56] M. Bjørås,et al. Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein. , 2010, Blood.
[57] K. Anderson,et al. PI3K/p110{delta} is a novel therapeutic target in multiple myeloma. , 2010, Blood.
[58] J. Debnath,et al. ATG12 Conjugation to ATG3 Regulates Mitochondrial Homeostasis and Cell Death , 2010, Cell.
[59] W. Kiosses,et al. Short-term fasting induces profound neuronal autophagy , 2010, Autophagy.
[60] H. Nagawa,et al. The inhibition of autophagy potentiates anti-angiogenic effects of sulforaphane by inducing apoptosis , 2010, Angiogenesis.
[61] Hong Liu,et al. Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase , 2010, Proceedings of the National Academy of Sciences.
[62] S. Minucci,et al. Histone deacetylases and epigenetic therapies of hematological malignancies. , 2010, Pharmacological research.
[63] Paul Workman,et al. Drugging the PI3 kinome: from chemical tools to drugs in the clinic. , 2010, Cancer research.
[64] P. Cohen,et al. Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index. , 2010, Cancer research.
[65] G. Robert,et al. Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation. , 2010, Cancer research.
[66] V. Longo,et al. Calorie restriction and cancer prevention: metabolic and molecular mechanisms. , 2010, Trends in pharmacological sciences.
[67] D. Ferguson,et al. Loss of autophagy in erythroid cells leads to defective removal of mitochondria and severe anemia in vivo , 2009, Proceedings of the National Academy of Sciences.
[68] T. Dorff,et al. Fasting and cancer treatment in humans: A case series report , 2009, Aging.
[69] M. Dyer,et al. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. , 2009, The Journal of clinical investigation.
[70] P. Greaney,et al. The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies. , 2009, Blood.
[71] J. Jankovic,et al. Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement , 2008, Neurobiology of Disease.
[72] Ying Zhao,et al. Vitamin D3 Induces Autophagy of Human Myeloid Leukemia Cells* , 2008, Journal of Biological Chemistry.
[73] C. Thompson,et al. Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation. , 2008, Blood.
[74] Changhan Lee,et al. Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy , 2008, Proceedings of the National Academy of Sciences.
[75] J. Guan,et al. FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells , 2008, The Journal of cell biology.
[76] Nektarios Tavernarakis,et al. Regulation of autophagy by cytoplasmic p53 , 2008, Nature Cell Biology.
[77] K. Nakayama,et al. Targeting the p27 E3 ligase SCF(Skp2) results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy. , 2008, Blood.
[78] S. Kondo,et al. Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma. , 2008, Experimental hematology.
[79] Nicholas E. Bruns,et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy , 2008, Proceedings of the National Academy of Sciences.
[80] John L Cleveland,et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes , 2008, Autophagy.
[81] S. Ramakrishnan,et al. Autophagy and Angiogenesis Inhibition , 2007, Autophagy.
[82] J. Cleveland,et al. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. , 2007, Blood.
[83] J. Duyster,et al. The anticancer drug imatinib induces cellular autophagy , 2007, Leukemia.
[84] Jie Jin,et al. Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1. , 2007, Leukemia research.
[85] M. Berger,et al. DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells , 2007, Cell Death and Differentiation.
[86] G. Evan,et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. , 2007, The Journal of clinical investigation.
[87] You-Wen He,et al. A critical role for the autophagy gene Atg5 in T cell survival and proliferation , 2007, The Journal of experimental medicine.
[88] P. Finn,et al. Proteolytic and lipolytic responses to starvation. , 2006, Nutrition.
[89] Y. Kondo,et al. Autophagy and Cancer Therapy , 2006, Autophagy.
[90] G. D. De Meyer,et al. In Situ Detection of Starvation-induced Autophagy , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[91] Govind Bhagat,et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. , 2003, The Journal of clinical investigation.
[92] Arnold J. Levine,et al. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[93] H. Hibshoosh,et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1 , 1999, Nature.
[94] Takeshi Noda,et al. Tor, a Phosphatidylinositol Kinase Homologue, Controls Autophagy in Yeast* , 1998, The Journal of Biological Chemistry.
[95] P. Allen,et al. Inhibition of autophagy abrogates tumour necrosis factor α induced apoptosis in human T‐lymphoblastic leukaemic cells , 1997, British journal of haematology.
[96] M. Rechsteiner,et al. Degradation of microinjected proteins: Effects of lysosomotropic agents and inhibitors of autophagy , 1983, Journal of cellular physiology.
[97] K. Saeki. [Degranulation of mast cells]. , 1983, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[98] D. Azarnoff. Drug interactions: Clinical significance , 1974, Clinical pharmacology and therapeutics.
[99] J. McCubrey,et al. AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications , 2012, Leukemia.
[100] R. Arceci,et al. Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival , 2012 .
[101] D. Rubinsztein,et al. Chemical modulators of autophagy as biological probes and potential therapeutics. , 2011, Nature chemical biology.
[102] J. Johnston,et al. p53 and autophagy contribute to dasatinib resistance in primary CLL lymphocytes. , 2011, Leukemia research.
[103] A. Ballestrero,et al. Proteasome inhibitors: antitumor effects and beyond , 2007, Leukemia.